Platform Talks

Sept 23

8:30am

Dr. Craig January

Discovery of hERG: Historical Perspectives and Contemporary Concern

Sept 23

10:00am

Co-chair:
Dr. Craig January

Emerging Technologies: Stem Cell Session

The field of stem cell research has been rapidly accelerating in the last several years. The development of validated human cell-based in vitro safety screens has the potential to facilitate earlier attrition of compounds with unacceptable safety profiles. This session will focus on recent efforts to develop a new source of pluripotent stem cells from somatic tissue and on the development of in vitro models using stem cell derived human tissue for drug safety evaluation.

Dr. James Thomson

Human-induced Pluripotent Stem (iPS) Cells: Implications for Drug Screening

Dr. Timothy Kamp

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Safety Pharmacology Applications

Poster Presentations

VivoMedica & CDI

Effects of Isoprenaline on Human Stem Cell-Derived Cardiomyocytes